[1] |
Ellingson TF. The uveitis-glaucoma-hyphema syndrome associated with the Mark Ⅷ anterior chamber lens implant[J]. Am Intra-Ocular Implant Society J, 1978, 4(2): 50-53.
|
[2] |
Du Y, Zhu X, Yang J, et al. Uveitis-glaucoma-hyphema syndrome with sclera-fixed posterior-chamber two-haptic intrao-cular lens in a highly myopic eye: a case report[J]. BMC Ophthalmology, 2020: 1-5.
|
[3] |
Armonaite L, Behndig A. Seventy-one cases of uveitis-glaucoma-hyphaema syndrome[J]. Acta Ophthalmol, 2021, 99(1):69-74.
|
[4] |
季樱红,荣先芳,卢奕.左眼葡萄膜炎-青光眼-前房积血综合征1例 [J].中国眼耳鼻喉科杂志,2021,2(21):23-27.
|
[5] |
Apple DJ, Mamlis N, Loftfield K, et al. Complications of intraocular lenses: a historical and histopathological review[J]. Surv Ophthalmol, 1984, 29: 1-54.
|
[6] |
Chan TC, Lok JK, Jhanji V, et al. Intraocular lens explantation in Chinese patients: different patterns and different responses[J]. Int Ophthalmol, 2015, 35(5): 679-684.
|
[7] |
Dalton M, Cheung A. UGH rare, but potentially devastating complication[J]. Ophthalmlogy Times, 2016, 30(2): 23-26.
|
[8] |
Lin CJ, Tan CY, Lin SY, et al. Uveitis-glaucoma-hyphaema syndrome caused by posterior chamber intraocular lens-a rare complication in pediatric cataract surgery[J]. Ann Ophthalmol, 2008, 40(3-4): 183-184.
|
[9] |
Capitena YCE, St-Peter DM, Ertel MK, et al. Hydrus Microstent malposition with uveitis-glaucoma-hyphema syndrome[J]. Am J Ophthalmol Case Rep, 2022, 9(25): 101405.
|
[10] |
Danny M, Michael AP, Joshua HO. Yoga-induced uveitis glaucoma hyphema syndrome[J]. Digit J Ophthalmol, 2020, 26(4): 46-48.
|
[11] |
Ellingson FT. Complications with the Choyce Mark Ⅷ anteriorchamber lens implant (uveitis-giaucoma-hyphema)[J]. Am Intra-Ocular Implant Soc J, 1977, 3: 199-201.
|
[12] |
Zhang L, Christopher T, Hood JP, et al. Mechanismsfor in-the-bag uveitis-glaucoma-hyphema syndrome [J].J Cataractefract Surg, 2014, 40: 490-492.
|
[13] |
Piette S, Canlas OA,Tran HV, et al. Ultrasound biomicroscopyin uveitis-glaucoma-hyphema syndrome[J]. Am J Ophthalmol, 2002, 133(6): 839-841.
|
[14] |
Mostafavi D, Nagel D, Danias J. Haptic-induced postoperative complications. Evaluation using ultrasound biomicroscopy[J]. Can J Ophthalmol, 2013, 48(6): 478-481.
|
[15] |
Kirk KR, Werner L, Jaber R, et al,Pathologic assessment of complications with asymmetric or sulcus fixation of square-edged hydrophobic acrylic intraocular lenses [J].Ophthalmology, 2012, 119: 907-913.
|
[16] |
Lima BR, Pichi F, Hayden BC, et al. Ultrasound biomicroscopy in chronic pseudophakic ocular inflammation associated with misplaced intraocular lens haptics[J]. Am J Ophthalmol, 2014 ,157(4): 813-817.
|
[17] |
Durr GM, Ahmed IIK. Intraocular lens complications: decentration, uveitis-glaucoma-hyphema syndrome, opacification, and refractive surprises[J].Ophthalmology, 2021, 128(11): e186-e194.
|
[18] |
Badakere SV, Senthil S, Turaga K, et al. Uveitis-glaucoma-hyphaema syndrome with in-the-bag placement of intraocular lens[J]. BMJ Case Rep, 2016, 11(1): 12-13.
|
[19] |
Zhang L, Hood CT, Vrabec JP, et al. Mechanisms for in-the-bag uveitis-glaucoma-hyphema syndrome[J]. J Cataract Refract Surg, 2014, 40(3): 490-492.
|
[20] |
Hou A, Hasbrook M, Crandall D. A case of uveitis-hyphema-glaucoma syndrome due to EX-PRESS glaucoma filtration device implantation[J]. J Glaucoma, 2019, 8(10): 159-161.
|
[21] |
Cheung AY, Price JM, Hart JCJ. Late-onset uveitis-glaucoma-hyphema syndrome caused by Soemmering ring cataract[J]. Can J Ophthalmol, 2019, 54(4): 445-450.
|
[22] |
Hanh M, Nguyen T. Uveitis-glaucoma-hyphaema syndrome[M]. Boston: New England Medical Center Grand Rounds, Tufts University, 1987.
|
[23] |
Yasser A, Khan YK, Pavlin CJ, et al. Uveitis-glaucoma-hyphema syndrome after handmade, anterior chamber lens implantation[J]. J Cataract Refract Surg, 1997, 23: 1414-1417.
|
[24] |
Alniemi ST, Amin SR, Sculley L, et al. Ultrasound Biomicroscopy in pseudophakic patients with unexplained recurrent hyphema or vitreous hemorrhage[J]. Semin Ophthalmol, 2018, 33(2): 260-264.
|
[25] |
Alfaro-Juárez A, Vital-Berral C, Sánchez-Vicente JL, et al. Uveitis-glaucoma-hyphaema syndrome associated with recurrent vitreous hemorrhage[J]. Arch Soc Esp Oftalmol, 2015, 90(8): 392-394.
|
[26] |
Sura AA, Reddy AK, Babic K, et al. Occult cause of uveitis-glaucoma-hyphema syndrome diagnosed during treatment with endocyclophotocoagulation (ECP) [J]. Am J Ophthalmol Case Rep, 2022, 12(26): 101537.
|
[27] |
Wu N, Zhang H, Chen B, et al. A novel application of B-ultrasonography at various head positions in the diagnosis of untypical uveitis-glaucoma-hyphema(UGH) syndrome[J]. Medicine, 2019, 98(2): e13891.
|
[28] |
Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease[J]. J Allergy Clin Immunol, 2007, 119(5): 1218-1224.
|
[29] |
Zhang L, Wan F, Song J, et al. Imbalance between Th17 cells and regulatory T cells during monophasic experimental autoimmune uveitis[J]. Inflammation, 2016, 39(1): 113-122.
|
[30] |
Zhou ZY, Chen SL, Shen N, et al. Cytokines and Behcet′s disease[J]. Autoimmun Rev, 2012, 11(10): 699-704.
|
[31] |
Sota J, Cantarini L, Vitale A, et al. Long-term outcomes of Behcet′s syndrome-related uveitis: a monocentric Italian experience[J/OL]. MediatorsInflamm, 2020: 6872402.
|
[32] |
Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behcet′s syndrome[J]. Ann Rheum Dis, 2018, 77(6): 808-818.
|
[33] |
Levy-Clarke G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders[J]. Ophthalmology, 2014, 121(3): 785-796.
|
[34] |
Smit D, Meyer D, Maritz J, et al. Polymerase chain reaction and goldmann-witmer coefficient to examine the role of epstein-barr virus in uveitis[J]. Ocul Immunol Inflamm, 2019, 27(1): 108-113.
|
[35] |
Iddawela D, Ehambaram K, Bandara P. Prevalence of toxocara antibodies among patients clinically suspected to have ocular toxocariasis: A retrospective descriptive study in Sri Lanka[J]. BMC Ophthalmol, 2017, 24, 17(1): 50.
|
[36] |
Mahalakshmi B, Therese KL, Madhavan HN, et al. Diagnostic value of specific local antibody production and nucleic acid amplification technique-nested polymerase chain reaction (nPCR) in clinically suspected ocular toxoplasmosis comparative study[J].Ocul Immunol Inflamm, 2006, 14(2): 105-112.
|
[37] |
Durand ML. Bacterial and fungal endophthalmitis[J]. Clin Microbiol Rev, 2017, 30(3): 597-613.
|
[38] |
Bardoloi N, Sarkar S, Burgute PS, et al. Capsular tension ring assisted phacoemulsification of morgagniancataract[J]. Indian J Ophthalmol, 2021, 69(7): 1781-1785.
|
[39] |
Rech L, Heckler L, Damji KF. Serial intracameral bevacizumab for uveitis-glaucoma-hyphema syndrome: a case report[J]. Can J Ophthal, 2014, 49: e160-e1602.
|
[40] |
孙世然,王首雁.人工晶状体植入术后葡萄膜炎-青光眼-前房积血综合征的临床分析[J]. 临床眼科杂志,2017,25(2):104-108.
|
[41] |
Bodh SA, Kumar V, Raina UK, et al. Inflammatory glaucoma[J]. Oman J Ophthalmol, 2011, 4(1): 3-9.
|
[42] |
Singh H, Modabber M, Safran SG, et al. Laser iridotomy to treat uveitis-glaucoma-hyphema syndrome secondary to reverse pupillary block in sulcus-placed intraocular lenses: case series[J]. J Cataract Refract Surg, 2015, 41(10): 2215-2223.
|
[43] |
Sousa DC, Leal I, Faria MY, et al. A rare manifestation of uveitis-glaucoma-hyphema syndrome[J]. J Curr Glaucoma Pract, 2016, 10(2): 76-78.
|
[44] |
Wintle R, Austin M. Pigment dispersion with elevated intraocular pressure after AcrySof intraocular lens implantation in the ciliary sulcus[J]. J Cataract Refract Surg, 2001, 27(4): 642-644.
|
[45] |
Foroozan R, Tabas JG, Moster ML. Recurrent microhyphema despite intracapsular fixation of a posterior chamber intraocular lens[J]. J Cataract Refract Surg, 2003, 29(8): 1632-1635.
|
[46] |
钱立峰,杨凯转,赵晓金,等.三点固定人工晶体睫状沟悬吊术临床观察[J]. 中华眼外伤职业眼病杂志,2017,39(3):226-228.
|
[47] |
陈桂英,唐耀冰,侯明佳. 人工晶状体睫状沟悬吊固定术治疗外伤眼的效果观察[J]. 中华眼外伤职业眼病杂志,2017,39(7):520-522.
|
[48] |
陈丽,刘思伟,刘明,等. 无囊膜支持眼巩膜内无缝线人工晶状体固定术[J]. 眼科新进展,2011,31(11):1065-1067.
|
[49] |
Takayama K, Akimoto M, Taguchi H, et al. Transconjunctival suture-less intrascleral intraocular lens fixation using intrascleral tunnels guided with catheter and 30-gauge needles[J]. Br J Ophthalmol, 2015, 99(11): 1457-1459.
|
[50] |
Jasinskas V, Vaiciuliene R, Varoniukaite A, et al. Novel microsurgical management of uveitis-glaucoma-hyphema syndrome[J]. Int Ophthalmol, 2019, 39(7): 1607-1612.
|
[51] |
Walland MJ. Uveitis-glaucoma-hyphaema syndrome treated with local laser iridoplasty[J]. Clin Exp Ophthal, 2017, 45: 647-648.
|
[52] |
Liu Z, Zhang F, Wen Y, et al. Diode laser transscleral cyclo-photocoagulation for uveitis-glaucoma-hyphema syndrome: A case report[J]. Medicine, 2020, 99(7): 1-3.
|
[53] |
Hermoso-Fernández FM, Gonzalez-Gallardo C, Cruz-Rojo M, et al. Retinal detachment in UGH Symdrome after cataract surgery[J]. Rom J Ophthalmol, 2021, 65(4): 395-398.
|
[54] |
Razeghinejad MR, Havens SJ. largecapsulorhexis related uveitis-glaucoma-hyphema syndrome managed by intraocular lens implant exchange and gonioscopy assisted transluminal trabeculotomy[J]. J Ophthalmic Vis Res, 2019, 14(2): 215-218.
|
[55] |
Elhusseiny AM, Lee RK, Smiddy WE. Surgical management of uveitis-glaucoma-hyphema syndrome[J]. Int J Ophthalmol, 2020, 13(6): 935-940.
|